1. Academic Validation
  2. Synthesis and preliminary biological evaluation of new antiproliferative aromatic analogues of 1α,25-dihydroxyvitamin D3

Synthesis and preliminary biological evaluation of new antiproliferative aromatic analogues of 1α,25-dihydroxyvitamin D3

  • Eur J Med Chem. 2014 Oct 30:86:381-93. doi: 10.1016/j.ejmech.2014.07.037.
Emmanuel Thomas 1 Jean-Daniel Brion 1 Jean-François Peyrat 2
Affiliations

Affiliations

  • 1 Laboratoire de Chimie Thérapeutique, BioCIS-CNRS (UMR 8076), Université Paris-Sud, Faculté de Pharmacie, Rue J.B. Clément, 92296 Châtenay-Malabry Cedex, France.
  • 2 Laboratoire de Chimie Thérapeutique, BioCIS-CNRS (UMR 8076), Université Paris-Sud, Faculté de Pharmacie, Rue J.B. Clément, 92296 Châtenay-Malabry Cedex, France. Electronic address: jean-francois.peyrat@u-psud.fr.
Abstract

In an effort to develop novel vitamin D3 analogues, a series of aromatic compounds was synthetized, using efficient Negishi cross coupling between alkenylzinc reagents of the C,D-ring moiety of vitamin D3, and various substituted aromatic halides as A-ring mimics. The study aimed at exploring the influence of the replacement of the original vitamin D3 diene by a styrene unit on the biological activities. Potency in the induction of the differentiation of HL-60 cells for the lead compound 36 was 12 fold less important than calcitriol correlating with a weaker binding affinity for VDR.

Keywords

Antiproliferative activity; Aromatic analogues of vitamin D3; Negishi coupling reaction.

Figures
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》